KATHERINE SMITH: Open Payments
NPI 1932979739 · GEORGETOWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$845 in 47 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $481 · 2025 $845
Food & beverage: $845
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $283 |
| Otsuka America Pharmaceutical, Inc. | 12 | $269 |
| Collegium Pharmaceutical, Inc. | 4 | $63 |
| Vanda Pharmaceuticals Inc. | 3 | $60 |
| Neurocrine BioSciences, Inc. | 2 | $41 |
| Janssen Pharmaceuticals, Inc | 1 | $25 |
| Lundbeck LLC | 1 | $22 |
| Noven Therapeutics, LLC | 1 | $20 |
| Tris Pharma Inc | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: VRAYLAR, REXULTI, Jornay PM, HETLIOZ, INGREZZA, SPRAVATO, Xelstrym, ABILIFY ASIMTUFII.
Industry payments across OH — which companies pay providers there.
